Leadership Team Expansion Announced by Command Medical: Includes William King & Chad Tremaroli

Command Medical Products has announced that William King and Chad Tremaroli are new additions to the Command Medical’s leadership team. King and Tremaroli Both filling new positions created to support the company’s focus on improved customer experience and sustaining the ongoing expansion of the organization.

William King joins Command Medical as the quality assurance and regulatory compliance manager. His prior role as quality systems and regulatory manager at Steris Isomedix bring excellent depth and experience in sterilization and regulatory compliance to the Command team. Bill’s previous positions at PerkinElmer and OMNIlife sciences support Command Medical’s strategic goals for optimization and improved customer experience in the quality and regulatory operations of the business. Bill has assumed the role of Command Medical’s management representative with the FDA and ISO notified body, SGS from Robert Wise. This transition of responsibilities will enable Robert to provide focused customer support in a variety of quality related contexts.

Chad Tremaroli has assumed the Director of Operations role at Command Medical’s Florida manufacturing facility. Previously, John Basham, who was also Director of Engineering, held this position. The splitting of this role into two separate functions aligns with Command Medical’s future strategic organizational structure. John will retain the Director of Engineering role as Chad focuses on operational improvements supported by his prior fourteen years’ experience working for Medtronic in senior leadership positions in logistics, distribution, continuous improvement and value stream management.

“It is an exciting time for Command Medical,” shared Jim Carnall, Command Medical’s president and COO. “Our vision to create a customer centric business is coming to fruition. Through transparent and responsive customer service, we are differentiating Command as a company that is truly focused on customer service beyond the traditional benchmarks of on time delivery and high quality. We offer direct communication to all department leaders and encourage open collaboration and sharing of knowledge with our clients. In order to support this while growing our business, we needed to add resources. The addition of Bill and Chad are key steps in our overall plan to meet our goal in providing legendary customer service.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.